Yimeng Du

1.3k total citations
45 papers, 988 citations indexed

About

Yimeng Du is a scholar working on Molecular Biology, Pharmaceutical Science and Biomedical Engineering. According to data from OpenAlex, Yimeng Du has authored 45 papers receiving a total of 988 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Pharmaceutical Science and 7 papers in Biomedical Engineering. Recurrent topics in Yimeng Du's work include Advanced Drug Delivery Systems (5 papers), Indoor Air Quality and Microbial Exposure (4 papers) and Nanoparticle-Based Drug Delivery (4 papers). Yimeng Du is often cited by papers focused on Advanced Drug Delivery Systems (5 papers), Indoor Air Quality and Microbial Exposure (4 papers) and Nanoparticle-Based Drug Delivery (4 papers). Yimeng Du collaborates with scholars based in China, United States and Hong Kong. Yimeng Du's co-authors include Aiping Zheng, Jing Gao, Philip W. T. Pong, Xiang Gao, Hui Zhang, Qinghua Lu, Jing Guo, Xiaowei Xing, P. T. Lai and Chen Wang and has published in prestigious journals such as Angewandte Chemie International Edition, Circulation and International Journal of Molecular Sciences.

In The Last Decade

Yimeng Du

42 papers receiving 975 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yimeng Du China 18 331 273 226 128 106 45 988
Yao Jin China 19 429 1.3× 347 1.3× 211 0.9× 184 1.4× 167 1.6× 40 1.2k
Chengyu Wu China 17 180 0.5× 195 0.7× 165 0.7× 147 1.1× 64 0.6× 67 1.0k
Takeo Urakami Japan 16 468 1.4× 403 1.5× 293 1.3× 201 1.6× 70 0.7× 21 1.2k
Yang Deng China 16 397 1.2× 201 0.7× 219 1.0× 59 0.5× 56 0.5× 28 889
Jingxin Mo China 19 361 1.1× 241 0.9× 250 1.1× 112 0.9× 193 1.8× 31 903
Thanh Huyền Trần United States 18 413 1.2× 310 1.1× 239 1.1× 195 1.5× 41 0.4× 32 1.1k
Xiaojun Tao China 23 588 1.8× 214 0.8× 315 1.4× 69 0.5× 128 1.2× 58 1.3k
Yan Gong China 17 230 0.7× 278 1.0× 260 1.2× 87 0.7× 38 0.4× 76 851
Yaxin Zheng China 20 614 1.9× 241 0.9× 194 0.9× 127 1.0× 140 1.3× 72 1.5k

Countries citing papers authored by Yimeng Du

Since Specialization
Citations

This map shows the geographic impact of Yimeng Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yimeng Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yimeng Du more than expected).

Fields of papers citing papers by Yimeng Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yimeng Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yimeng Du. The network helps show where Yimeng Du may publish in the future.

Co-authorship network of co-authors of Yimeng Du

This figure shows the co-authorship network connecting the top 25 collaborators of Yimeng Du. A scholar is included among the top collaborators of Yimeng Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yimeng Du. Yimeng Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xue, Chunyuan, Yimeng Du, Jigui Shan, et al.. (2025). TIMM10 enhances MAVS mediated innate immune response against influenza A virus infection. Colloids and Surfaces A Physicochemical and Engineering Aspects. 718. 136900–136900.
2.
Du, Yimeng, et al.. (2024). Modular development of organelle-targeting fluorescent probes for imaging formaldehyde in live cells. Analytical Methods. 16(23). 3646–3653. 4 indexed citations
3.
Yang, Hongrui, Ning Xiang, Yanyan Ma, et al.. (2024). Sacubitril/valsartan reversal of left ventricular remodeling is associated with improved hemodynamics in resistant hypertension. Hellenic Journal of Cardiology. 84. 51–60. 1 indexed citations
4.
Hu, Lijun, Yimeng Du, Rui Liu, et al.. (2024). Alkali metal cation adsorption–induced surface polarization in polymeric carbon nitride for enhanced photocatalytic hydrogen peroxide production. Journal of Colloid and Interface Science. 679(Pt A). 456–464. 10 indexed citations
5.
Du, Yimeng, et al.. (2024). Patterns of use of advanced wound matrices in the Veterans Administration clinics. Wound Repair and Regeneration. 32(2). 118–122. 1 indexed citations
6.
Hu, Lijun, et al.. (2023). Inhibition of superoxide radical diffusion by Van der Waals forces for boosting photocatalytic H2O2 production. Applied Surface Science. 638. 158135–158135. 17 indexed citations
7.
Du, Yimeng, Erin G. Brown, Payam Saadai, et al.. (2023). Evolution and Variations of the Ovine Model of Spina Bifida. Fetal Diagnosis and Therapy. 50(6). 491–500.
8.
9.
Liu, Nan, Zengming Wang, Jing Gao, et al.. (2021). Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier. Molecules. 27(1). 204–204. 41 indexed citations
10.
Gao, Xiang, et al.. (2020). Size, shape, charge and “stealthy” surface: Carrier properties affect the drug circulation time in vivo. Asian Journal of Pharmaceutical Sciences. 16(4). 444–458. 185 indexed citations
11.
Du, Yimeng, et al.. (2019). Magnetic iron oxide nanoparticle-hollow mesoporous silica Spheres:Fabrication and potential application in drug delivery. Current Applied Physics. 20(2). 320–325. 38 indexed citations
12.
Xin, Bo‐Tao, E.M. Huber, Gerjan de Bruin, et al.. (2019). Structure-Based Design of Inhibitors Selective for Human Proteasome β2c or β2i Subunits. Journal of Medicinal Chemistry. 62(3). 1626–1642. 28 indexed citations
13.
Guo, Jing, et al.. (2019). Therapy for myocardial infarction: In vitro and in vivo evaluation of puerarin-prodrug and tanshinone co-loaded lipid nanoparticulate system. Biomedicine & Pharmacotherapy. 120. 109480–109480. 25 indexed citations
14.
Li, Lei, Ye Liu, Shao‐Fei Ni, et al.. (2017). Phosphine-catalyzed remote α-C–H bond activation of alcohols or amines triggered by the radical trifluoromethylation of alkenes: reaction development and mechanistic insights. Organic Chemistry Frontiers. 4(11). 2139–2146. 29 indexed citations
15.
Wang, Wenke, Qinghua Lu, Ben Wang, et al.. (2017). Ulinastatin attenuates diabetes-induced cardiac dysfunction by the inhibition of inflammation and apoptosis. Experimental and Therapeutic Medicine. 14(3). 2497–2504. 14 indexed citations
16.
Ma, Weihong, Yimeng Du, Yibiao Wang, et al.. (2012). Association between human cartilage glycoprotein 39 (YKL-40) and arterial stiffness in essential hypertension. BMC Cardiovascular Disorders. 12(1). 35–35. 28 indexed citations
17.
Du, Yimeng, et al.. (2011). Prognostic Value of Serum LP-PLA2 and hs-CRP in Unstable Atherosclerotic Plaques. Clinical and Experimental Hypertension. 33(2). 113–116. 3 indexed citations
18.
Gong, Huiping, et al.. (2011). Plasma Lipoprotein-associated Phospholipase A2 in Patients with Metabolic Syndrome and Carotid Atherosclerosis. Lipids in Health and Disease. 10(1). 13–13. 25 indexed citations
19.
Zhang, Yun, et al.. (2008). Increased plasma osteoprotegerin levels are associated with the presence and severity of acute coronary syndrome. Acta Cardiologica. 63(5). 615–622. 15 indexed citations
20.
Lu, Qinghua, et al.. (2005). [Plasma activated coagulation factor VII and Msp I polymorphism in elderly patients with coronary heart disease].. PubMed. 22(6). 691–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026